title: A short review of drug-food interactions of medicines treating overactive bladder syndrome.
abstract: Background Overactive bladder syndrome is a condition where one or more of the symptoms such as pollakiuria, urgent need to urinate, nocturia and urinary incontinence is observed. Its prevalence ranges between 7 and 27 % in men and 9-43 % in women. The role of a pharmacist is to educate the patient on medications administration scheme, and drug interactions with particular food or food components. Aim of the review To assess a potential impact of food and fruit juice on the pharmacokinetic and therapeutic effects of medications used in treating overactive bladder syndrome. This information will enhance pharmaceutical care and is vital and helpful for pharmacists counseling their patients. Method In order to gather information on interactions of medications employed in bladder dysfunctions, the English language reports published in the PubMed, Embase, Cochrane and CINAHL database over the years 1996-2015 were studied. Additionally, other resources, namely drugs.com, Medscape, UpToDate, Micromedex, Medical Letter, as well as Stockley Drugs Interaction electronic publication were included in the study. The analysis also covered product data sheets for particular medicinal products. Results Meals and the consumption of grapefruit juice were found to exert a diversified effect on the pharmacokinetics of drugs employed in overactive bladder syndrome therapy. Neither tolterodine, nor mirabegron interact with food and citrus fruit juice, whereas darifenacin, fesoterodine, oxybutynin and solifenacin do interact with grapefruit and others citrus fruit juice. The effects of such interactions may potentially be negative to patients. Trospium absorption is significantly decreased by food. Conclusion For selected medicines used in treating bladder dysfunctions food and grapefruit juice consumption may significantly affect efficacy and safety of the therapy. All information on the topic is likely to enhance the quality of pharmaceutical care.
authors.affiliation: Department of Food Chemistry and Nutrition, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Medyczna 9, 30-688, Kraków, Poland. paskopaw@poczta.fm.
authors.forename: Paweł
authors.initials: P
authors.lastname: Paśko
authors.affiliation: Department of Food Chemistry and Nutrition, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Medyczna 9, 30-688, Kraków, Poland.
authors.forename: Tomasz
authors.initials: T
authors.lastname: Rodacki
authors.affiliation: Department of Gastroenterology, Hepatology and Infectious Diseases, Faculty of Medicine, Jagiellonian University Medical College, 31-531, Kraków, Poland.
authors.forename: Renata
authors.initials: R
authors.lastname: Domagała-Rodacka
authors.affiliation: Department of Gastroenterology, Hepatology and Infectious Diseases, Faculty of Medicine, Jagiellonian University Medical College, 31-531, Kraków, Poland.
authors.forename: Danuta
authors.initials: D
authors.lastname: Owczarek
mesh_terms: D018680:Cholinergic Antagonists / Q000009:adverse effects / Q000378:metabolism*; D018565:Food-Drug Interactions / Q000502:physiology*; D000067030:Fruit and Vegetable Juices; D006801:Humans; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D018680:Cholinergic Antagonists
keywords: Anticholinergic drugs; Drugs–food interactions; Overactive bladder syndrome; Review; Urinary incontinence